Research we are currently funding:
Dr Micklethwaite and his team aim to create a new class of CAR T-cells that are capable of recognising and attacking acute myeloid leukaemia cells with a high degree of accuracy.
Dr Wong’s research is focused on the chemical changes in DNA and RNA that are associated with acute myeloid leukaemia.
Genetically modified immune cells can be used to cure cases of leukaemia that are otherwise incurable. This project will optimise the technology to create cures for other types of cancer.
Professor Gottlieb is determining the best combination of bone marrow transplant methods that can be used to improve patient outcomes
The aim of this 5 year program is to increase survival rates of children with Acute Lymphoblastic Leukaemia (ALL) and ultimately develop prevention strategies.
Dr Wang is exploring possible new treatments for acute myeloid leukaemia by targeting leukemic stem cells.
Impact we've achieved with our research:
Prof David Gottlieb's research arose out of a desire to overcome poor outcomes in clinical practice. He wants to develop better treatments that can have direct and clear benefits for patient
Prof David Gottlieb's research has discovered that the treatment of using enhanced white blood cells to fight infection and leukemia can reduce side effects in bone marrow transplant recipie
One of Murray’s proudest achievements so far has been the development of unique technology that helps prevent relapse in children with acute lymphoblastic leukaemia.
Professor Murray Norris and his team developed a pioneering tool that is improving the survival of children with leukaemia by stopping the cancer from returning.